Financial Summary (All financials)
| In millions, except per share items | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 |
| Revenues | 129.8 | 101.3 | 73.8 | 49.5 | 8.3 |
| Revenue growth | 28.1% | 37.2% | 49.2% | 500.0% | |
| Cost of goods sold | 58.8 | 45.2 | 30.5 | 30.8 | 5.1 |
| Gross profit | 70.9 | 56.1 | 43.4 | 18.7 | 3.1 |
| Gross margin | 54.7% | 55.4% | 58.8% | 37.8% | 38.2% |
| Sales and marketing | 34.2 | 20.5 | 20.6 | 12.3 | 3.8 |
| Research and development | 30.5 | 22.8 | 23.3 | 15.0 | 6.5 |
| General and administrative | 23.4 | 20.6 | 14.1 | 10.6 | 3.0 |
| EBITA | -15.0 | -6.2 | -12.0 | -17.2 | -10.2 |
| EBITA margin | -11.6% | -6.1% | -16.3% | -34.7% | -123.3% |
| Amortization of intangibles | 2.1 | 1.5 | 2.5 | 2.0 | |
| EBIT | -17.1 | -7.7 | -14.6 | -19.2 | -10.2 |
| EBIT margin | -13.2% | -7.6% | -19.7% | -38.8% | -123.3% |
| Pre-tax income | -25.5 | -12.8 | -14.4 | -20.4 | -10.3 |
| Income taxes | 0.5 | 2.5 | 1.2 | 1.3 | 0.1 |
| Net income | -26.0 | -15.3 | -15.6 | -21.8 | -10.4 |
| Net margin | -20.1% | -15.1% | -21.1% | -44.0% | -126.0% |
| |
| Diluted EPS | ($1.00) | ($3.57) | ($12.09) | ($18.82) | ($9.41) |
| Shares outstanding (diluted) | 26.0 | 4.3 | 1.3 | 1.2 | 1.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|